APP and Alzheimer disease: To determine if elevated p-eIF2α contributes to the development of AD, researchers reduced levels of p-eIF2α by deleting PERK or GCN2 in APP/PS1 mice, allowing translation to occur, which improved synaptic plasticity [108].